<!DOCTYPE html><html lang="en"><head><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width,initial-scale=1"><title>Infarction Shock and DIC - BHOLE</title><meta name="description" content="InfarctionShockCauses:Categories:Stages:Septic ShockDisseminated Intravascular CoagulationConsequences of DICInfarctionInfarction is the process of ischemic necrosis due to either occlusion of arterial supply or of venous drainage.Mainly due to interruption of arterial supply, even if caused by a venous event.Thrombotic events: eg DVT travels to lungs and then occludes&hellip;"><meta name="generator" content="Publii Open-Source CMS for Static Site"><link rel="canonical" href="https://BGASM.github.io/medNotes/infarction-shock-and-dic.html"><link rel="alternate" type="application/atom+xml" href="https://BGASM.github.io/medNotes/feed.xml"><link rel="alternate" type="application/json" href="https://BGASM.github.io/medNotes/feed.json"><meta property="og:title" content="Infarction Shock and DIC"><meta property="og:image" content="https://BGASM.github.io/medNotes/media/posts/8/Myelolipoma_histology_HE.jpg"><meta property="og:site_name" content="BHOLE"><meta property="og:description" content="InfarctionShockCauses:Categories:Stages:Septic ShockDisseminated Intravascular CoagulationConsequences of DICInfarctionInfarction is the process of ischemic necrosis due to either occlusion of arterial supply or of venous drainage.Mainly due to interruption of arterial supply, even if caused by a venous event.Thrombotic events: eg DVT travels to lungs and then occludes&hellip;"><meta property="og:url" content="https://BGASM.github.io/medNotes/infarction-shock-and-dic.html"><meta property="og:type" content="article"><link rel="preconnect" href="https://fonts.gstatic.com/" crossorigin><link href="https://fonts.googleapis.com/css?family=Open+Sans:400,700|Roboto:400,700&amp;subset=latin-ext&amp;display=swap" rel="stylesheet"><style>:root{--body-font:'Open Sans',sans-serif;--heading-font:'Roboto',sans-serif;--logo-font:'Roboto',sans-serif;--menu-font:'Roboto',sans-serif}</style><link rel="stylesheet" href="https://BGASM.github.io/medNotes/assets/css/style.css?v=d2564d8d5f32cbb5488692bb93d80cc5"><script type="application/ld+json">{"@context":"http://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://BGASM.github.io/medNotes/infarction-shock-and-dic.html"},"headline":"Infarction Shock and DIC","datePublished":"2020-12-03T01:34","dateModified":"2020-12-03T01:34","image":{"@type":"ImageObject","url":"https://BGASM.github.io/medNotes/media/posts/8/Myelolipoma_histology_HE.jpg","height":768,"width":1024},"description":"InfarctionShockCauses:Categories:Stages:Septic ShockDisseminated Intravascular CoagulationConsequences of DICInfarctionInfarction is the process of ischemic necrosis due to either occlusion of arterial supply or of venous drainage.Mainly due to interruption of arterial supply, even if caused by a venous event.Thrombotic events: eg DVT travels to lungs and then occludes&hellip;","author":{"@type":"Person","name":"William Slattery"},"publisher":{"@type":"Organization","name":"William Slattery"}}</script></head><body><div class="site-container"><header class="top" id="js-header"><a class="logo" href="https://BGASM.github.io/medNotes/">BHOLE</a><nav class="navbar js-navbar"><button class="navbar__toggle js-toggle" aria-label="Menu" aria-haspopup="true" aria-expanded="false"><span class="navbar__toggle-box"><span class="navbar__toggle-inner">Menu</span></span></button><ul class="navbar__menu"><li><a href="https://github.com/BGASM" target="_self">My Github</a></li><li class="has-submenu"><span class="is-separator" aria-haspopup="true">Pharmacology</span><ul class="navbar__submenu level-2" aria-hidden="true"><li><a href="https://BGASM.github.io/medNotes/adrenergic-and-cholinergic-systems.html" target="_self">Adrenergic and Cholinergic I</a></li><li><a href="https://BGASM.github.io/medNotes/adrenergic-and-cholinergic-systems-ii.html" target="_self">Adrenergic and Cholinergic II</a></li><li><a href="https://BGASM.github.io/medNotes/adrenergic-and-cholinergic-pharm-iii.html" target="_self">Adrenergic and Cholinergic III</a></li><li><a href="https://BGASM.github.io/medNotes/adrenergic-inhibitors.html" target="_self">Adrenergic Inhibitors</a></li><li><a href="https://BGASM.github.io/medNotes/chemotherapy-i.html" target="_self">Chemotherapy I</a></li><li><a href="https://BGASM.github.io/medNotes/chemotherapy-ii.html" target="_self">Chemotherapy II</a></li></ul></li><li class="active-parent has-submenu"><span class="is-separator" aria-haspopup="true">Pathophysiology</span><ul class="navbar__submenu level-2" aria-hidden="true"><li><a href="https://BGASM.github.io/medNotes/edema-congestion-and-hemostasis.html" target="_self">Edema Congestion and Hemostasis</a></li><li><a href="https://BGASM.github.io/medNotes/hemorrhage-thrombosis-and-embolism-2.html" target="_self">Hemorrhage Thrombosis and Embolism</a></li><li class="active"><a href="https://BGASM.github.io/medNotes/infarction-shock-and-dic.html" target="_self">Infarction Shock and DIC</a></li></ul></li></ul></nav></header><main><article class="post"><div class="hero"><figure class="hero__image hero__image--overlay"><img src="https://BGASM.github.io/medNotes/media/posts/8/Myelolipoma_histology_HE.jpg" srcset="https://BGASM.github.io/medNotes/media/posts/8/responsive/Myelolipoma_histology_HE-xs.jpg 300w, https://BGASM.github.io/medNotes/media/posts/8/responsive/Myelolipoma_histology_HE-sm.jpg 480w, https://BGASM.github.io/medNotes/media/posts/8/responsive/Myelolipoma_histology_HE-md.jpg 768w, https://BGASM.github.io/medNotes/media/posts/8/responsive/Myelolipoma_histology_HE-lg.jpg 1024w, https://BGASM.github.io/medNotes/media/posts/8/responsive/Myelolipoma_histology_HE-xl.jpg 1360w, https://BGASM.github.io/medNotes/media/posts/8/responsive/Myelolipoma_histology_HE-2xl.jpg 1600w" sizes="(max-width: 1600px) 100vw, 1600px" loading="eager" height="768" width="1024" alt=""></figure><header class="hero__content"><div class="wrapper"><div class="post__meta"><time datetime="2020-12-03T01:34">December 3, 2020</time></div><h1>Infarction Shock and DIC</h1><div class="post__meta post__meta--author"><a href="https://BGASM.github.io/medNotes/authors/william-slattery/" class="feed__author invert">William Slattery</a></div></div></header></div><div class="wrapper post__entry"><ul><li><a href="#infarction">Infarction</a></li><li><a href="#shock">Shock</a><ul><li><a href="#causes">Causes:</a></li><li><a href="#categories">Categories:</a></li><li><a href="#stages">Stages:</a></li></ul></li><li><a href="#septic-shock">Septic Shock</a></li><li><a href="#disseminated-intravascular-coagulation">Disseminated Intravascular Coagulation</a><ul><li><a href="#consequences-of-dic">Consequences of DIC</a><h1 id="infarction">Infarction</h1></li></ul></li><li>Infarction is the process of ischemic necrosis due to either occlusion of arterial supply or of venous drainage.</li><li>Mainly due to interruption of arterial supply, even if caused by a venous event.<ul><li>Thrombotic events: <em>eg</em> DVT travels to lungs and then occludes <strong>arterial</strong> pulmonary artery.</li><li>Vasospasm</li><li>Extrinsic compression by tumor, edema, entrapment in hernia</li><li>Twisting/Torsion</li><li>Vessel rupture</li><li>Venous thrmobosis in organs with single venous outflow.<h2 id="infarct-outcome">Infarct Outcome</h2><ul><li>Dual blood supply (lung, liver, extremities)</li><li>Rate of occlusion: slower occlusion time allow for collateral circulation</li><li>Tissueâ€™s vulnerability to hypoxis<ul><li>Neurons: 3-4 minutes</li><li>Myocardial: 20-30</li><li>Fibroblasts: hours<h2 id="gross-morphology">Gross Morphology</h2></li></ul></li><li>Wedge shaped</li><li>Occluded vessel at apex, organ at base</li><li>Acute poorly defined and slightly hemorrhagic</li><li>Chronic defined with a <em>narrow rim of congestion</em> due to the inflammatory response</li><li>Red vs. White</li><li>Septic vs. Bland<h3 id="red-infarct">Red Infarct</h3><ul><li>RBC-rich blood present</li><li>Venous occlusion</li><li>Loose tissue (lung)</li><li>Dual blood supply</li><li>Congested</li><li>Previous occluison or necrosis.<h3 id="white-infarct">White Infarct</h3></li><li>Organs with end-arterial supply (<em>heart, spleen, kidney</em>)</li><li>Anemic</li><li>Due to lack of nutrients into necrotic zone.<h3 id="septic">Septic</h3></li><li>Occur when infected heart valve vegetation embolize</li><li>Occur when microbes seed an area of necrosis<h2 id="microscopic-morphology">Microscopic Morphology</h2></li></ul></li><li>characterized by ischemic coagulative necrosis<ul><li>Timeline:<ul><li>No visible histologic changes are the norm if ischemia occurs within minutes to a fewhours before death</li><li>4-12 hours, tissue necrosis begins to appear, and acute inflammation begins to show up around the edges</li><li>1-2 days, tissue necrosis is established, and the peripheral inflammatory response is well-defined</li><li>Reparative process follows over the next several days to weeks, where necrotic tissue is removed, and scar tissue replaces<h1 id="shock">Shock</h1></li></ul></li></ul></li></ul></li></ul></li><li>Systemic hypoperfusion due to reduced cardiac output or blood volume<h2 id="causes">Causes:</h2><ul><li>Severe hemorrhage</li><li>Extensive trauma</li><li>Large myocardial infarction</li><li>Massive PE</li><li>Septicemia<h2 id="categories">Categories:</h2><ol><li>Cardiogenic shock:<ul><li>outflow obstruction (PE)</li><li>myocardial pump failure (myocardial infection, arrhythmia, or pericardial tamponade)</li></ul></li><li>Hypovolemic shock:<ul><li>extensive hemorrhage and/or fluid loss (burns, trauma, vomiting, diarrhea)</li></ul></li><li>Septic shock:<ul><li>vasodilation and peripheral blood pooling caused by overwhelming microbial infection and associated immune response</li></ul></li><li>Neurogenic shock:<ul><li>rarer cause with loss of vascular tone and peripheral pooling (anesthetic accident, spinal cord injury)</li></ul></li><li>Anaphylactic shock:<ul><li>rarer cause with systemic vasodilation and increased vascular permeability (IgE-mediated hypersensitivity)<h2 id="stages">Stages:</h2></li></ul></li></ol><ul><li>Non-progressive:<ul><li>Reflex neurohumoral compensatory mechanisms are activated (catecholamines, ADH, renin-angiotensin axis, etc.)</li><li>Produces tachycardia, peripheral vasoconstriction, and renal conservation of fluid.</li><li>Perfusion of vital organsmaintained.</li></ul></li><li>Progressive:<ul><li>Occurs when persistent hypoxemia leads to anaerobic glycolysis, lactic acid generation, and decreased tissue pH</li><li>This reduces vasomotor response</li><li>Leads to vasodilation, peripheral pooling, decreased CO, ultimately tissue hypoxia</li></ul></li><li>Irreversible:<ul><li>When re-perfusion will not correct death spiral</li><li>Ischemic bowel may lead to superimposed bactermia/septic shock</li><li>Renal failure and tubular necrosis can lead to anuria<h2 id="morphology">Morphology:</h2><h3 id="lungs">Lungs:</h3></li></ul></li></ul></li><li>Diffuse alveolar damage<ul><li>Sepsis or trauma</li></ul></li><li>Hyaline membranes lining alveolar spaces</li><li>Interstitial inflammation<h3 id="kidneys">Kidneys:</h3></li><li>Acute tubular necrosis causes oliguira, anuria, electrolyte disturbances</li><li>Swollen vacuolated tubular cells with necrosis and tubular casts<h3 id="brain">Brain:</h3></li><li>Red neurons and neuronal loss<h3 id="adrenals">Adrenals:</h3></li><li>Coritcal cell lipid depletion<h3 id="gi">GI:</h3></li><li>Ischemia with mucosal breakdown<h3 id="skin">Skin:</h3></li><li>Petechial hemorrhage<h2 id="clinical-consequences">Clinical Consequences:</h2></li><li>Cardiogenic and hypovolemic:<ul><li>Hypotension, weak rapid pulse, tachypnea, cool cyanotic skin.</li></ul></li><li>Septic Shock:<ul><li>Skin warm and flushed</li></ul></li><li>Most healthy PT survive hypovolemic shock</li><li>Cardiogenic and spetic are less survivable<h1 id="septic-shock">Septic Shock</h1></li></ul></li><li>Most common in infection by G+/- bacteria and fungi</li><li>Several factors in causation:<ul><li>Inflammatory and counter-inflammatory response</li><li>Endothelia cell activation/injury leading to increased thrombotic, vasodilation, permeability and edema</li><li>DIC</li><li>Metabolic abnormalities<ul><li>Adrenal gland necrosis due to DIC is named Waterhouse-Friderichson Syndrome</li></ul></li><li>Organ dysfunction when systemic hypotension, interstitial edema, small vessel thrombosis all decrease oxygen to organs.<ul><li>Decreased cardiac contractility can lead to cardiovascular collapse</li><li>Increased vascular permeability and endothelial injury lead to lung failure</li><li>Anuria can develop due to acute tubular necrosis or renal failure</li><li>Multiorgan failure: liver, adrenals, etc.<h1 id="disseminated-intravascular-coagulation">Disseminated Intravascular Coagulation</h1></li></ul></li><li>Acute, Subacute, or chronic thrombohemorrhagic disorder.</li><li>Excessive activation of coagulation and thrombi formation.</li><li>Not a primary disease. A secondary response to disease.<h2 id="triggers-for-dic">Triggers for DIC</h2><ul><li>Bacterial endotoxins can inhibit endothelial thrombomodulin production.<ul><li>Endotoxins can also activate factor XII</li></ul></li><li>Antigen-Ab complexes can activate classical complement pathway - which leads to complement fragments that activate platelets and granulocytes</li><li>Massive trauma causes tissue factor release</li><li>Placenta procoagulant proteins can enter circulation</li><li>Hypoxia, acidosis, shock</li><li>Leukemia and adenocarcinomas</li></ul></li><li><strong>Activation of the coagulation cascade and excess thrombin will lead to microthrombi (fibrin thrombi) in tiny vessels throughout the body</strong><ul><li>Fibrin thrombia create ischemia in organs and tissue.</li><li>Compensation for excess fibrin thrombi: â†‘â†‘â†‘ coagulation inhibitors and fibrinolytic proteins</li><li>Simultaneous consumption of both <strong>procoagulant</strong> and <strong>anticoagulant</strong> proteins exhausts the bodyâ€™s ability to create more</li><li><strong>End stage: bleeding</strong><h2 id="consequences-of-dic">Consequences of DIC</h2></li><li>Widespread deposition of fibrin</li><li>Ischemia</li><li>Microangipathic hemolytic anemia (<em>RBC fragment trying to squeeze through narrow vasculature</em>)</li><li>Hemorrhagic diathesis as clotting factors and platelets are consumed</li></ul></li></ul></li></ul></div><footer class="wrapper post__footer"><p class="post__last-updated">This article was updated on December 3, 2020</p></footer></article><nav class="post__nav"><div class="post__nav-inner"><div class="post__nav-prev"><svg width="1.041em" height="0.416em" aria-hidden="true"><use xlink:href="https://BGASM.github.io/medNotes/assets/svg/svg-map.svg#arrow-prev"/></svg> <a href="https://BGASM.github.io/medNotes/adrenergic-inhibitors.html" class="invert post__nav-link" rel="prev"><span>Previous</span> Adrenergic Inhibitors</a></div><div class="post__nav-next"><a href="https://BGASM.github.io/medNotes/chemotherapy-i.html" class="invert post__nav-link" rel="next"><span>Next</span> Chemotherapy I </a><svg width="1.041em" height="0.416em" aria-hidden="true"><use xlink:href="https://BGASM.github.io/medNotes/assets/svg/svg-map.svg#arrow-next"/></svg></div></div></nav></main><footer class="footer"><div class="footer__copyright"><p>Powered by <a href="https://getpublii.com" target="_blank" rel="nofollow noopener">Publii</a></p></div><button class="footer__bttop js-footer__bttop" aria-label="Back to top"><svg><title>Back to top</title><use xlink:href="https://BGASM.github.io/medNotes/assets/svg/svg-map.svg#toparrow"/></svg></button></footer></div><script>window.publiiThemeMenuConfig = {    
        mobileMenuMode: 'overlay',
        animationSpeed: 300,
        submenuWidth: 'auto',
        doubleClickTime: 500,
        mobileMenuExpandableSubmenus: true, 
        relatedContainerForOverlayMenuSelector: '.top',
   };</script><script defer="defer" src="https://BGASM.github.io/medNotes/assets/js/scripts.min.js?v=f4c4d35432d0e17d212f2fae4e0f8247"></script><script>var images = document.querySelectorAll('img[loading]');

        for (var i = 0; i < images.length; i++) {
            if (images[i].complete) {
                images[i].classList.add('is-loaded');
            } else {
                images[i].addEventListener('load', function () {
                    this.classList.add('is-loaded');
                }, false);
            }
        }</script></body></html>